Asset Publisher

Live stream

AI x Biotech: Its Cybersecurity Implications

Publication Launch: Cybersecurity Implications of the Convergence between AI and Biotechnology

The convergence of AI and biotechnology is unlocking life-saving medical innovations. However, it is also opening doors to a new class of cyber threats, including targeted data breaches, adversarial AI, and the manipulation of biomedical research. We asked Eleonore Pauwels, a senior fellow with the Global Center on Cooperative Security, to analyze these threats and possible solutions to cyber-protect the bioeconomy. Join us to discuss the study's results with the author and a panel of distinguished experts.
April 16, 2025 11:00 o'clock

Asset Publisher

Details

Please click here to view contents.
Or adjust your cookie settings under privacy policy.

 

Panel:

 

  • Sultan Meghji, Co-Founder and CEO, Frontier Foundry. Former Chief Innovation Officer, FDIC.
  • Dr. Sofonias K. Tessema, Program Lead for Pathogen Genomics, Africa CDC.
  • Dr. Sterling Sawaya, Founder and CEO, GeneInfoSec.
  • Eleonore Pauwels, Senior Fellow, Global Center on Cooperative Security.

Asset Publisher

Date and time

April 16, 2025
11:00 o'clock
Add to calendar

Publication

AI x Biotech: Its Cybersecurity Implications: Cybersecurity Implications of the Convergence between AI and Biotechnology
Apr 8, 2025
Read now
Contact

Dirk Hegen

Dirk Hegen KAS

Senior Policy Advisor

Dirk.Hegen@kas.de + 1 202 464 5847